This report aims to provide insights into the global Transfection Reagents and Equipment Market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Target Audience for this Report:
# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists
Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146
Factors Influencing Global Growth:-
This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.
Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market.
Restraints:
# Selective Effectiveness of Transfection Reagents
# Home Brew Reagents Restrict Sale of Commercial Kits
# High Cost of Transfection Reagents
Opportunities:
# Large-Scale Transfections
# High-Growth Opportunities in Asian Market
Challenges:
# Transfection in Hard-To-Transfect Cells
# Cytotoxicity in Transfection – A Major Concern
Monetary Growth Expectations, Globally:
This report studies the global transfection reagents and equipment market from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
Geographical Growth Scenario:
On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Leading Market Players:
# Thermo Fisher Scientific Inc. (U.S.)
# Promega Corporation (U.S.)
# Hoffmann-La Roche Ltd. (Switzerland)
# QIAGEN N.V. (Netherlands) and many more…
Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence.
